Foreign Product Alert: Body Con Plus capsules, Physic Candy - Define, 7-Day Slim Extreme capsules

Starting date:

October 27, 2017

Type of communication:

Foreign Product Alert (FPA)

Subcategory:

Natural health products

Source of recall:

Health Canada

Identification number:

RA-64984

• 
  Issue
• 
  What you should do
• 
  Background
• 
  Report health or safety concerns
• 
  Images

Issue

These foreign health products have been found by regulators in other countries to contain undeclared drug ingredients.

The products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Unauthorized Foreign Health Products

Product Name(s)	Hazard(s) Identified	Source of Alert	Images
Unauthorized Weight Loss Products
Body Con Plus capsules	Undeclared sibutramine and phenolphthalein	Australia Therapeutic Goods Administration
Physic Candy - Define	Undeclared sibutramine	United States Food and Drug Administration
7-Day Slim Extreme capsules	Undeclared sibutramine	Australia Therapeutic Goods Administration

What you should do

• Contact Health Canada at 1-800-267-9675 or by completing an online complaint form if you find a product listed above in the Canadian marketplace.

• Consult a healthcare professional if you have health concerns related to the use of any of these products.

• Read the label of the products you buy to verify that they have been assessed by Health Canada for safety, effectiveness and quality. Health products that have been authorized for sale by Health Canada will have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM).

Background

Prescription drugs should only be used under the supervision of a healthcare professional.

Phenolphthalein was previously used as a laxative, but is no longer authorized for sale in Canada because it may cause cancer. Additional side effects include decreased blood pressure, skin rash, and gastrointestinal bleeding.

Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke. Other side effects include increased blood pressure and heart rate, dry mouth, difficulty sleeping, and constipation.

Report health or safety concerns

To report a side effect for a health product to Health Canada:

• call toll-free at 1-866-234-2345; or
• visit Health Canada's webpage on Adverse Reaction Reporting for information on how to report online, by mail, or by fax.

As of October 12, 2017, no adverse reactions suspected to be associated with the use of these products have been reported to Health Canada.

Images

Select thumbnail to enlarge - opens in a new window